Publications by authors named "J Schutte"
A patient with a long history of bone predominant, metastatic paraganglioma who had multiple episodes of progressive disease despite prior treatments demonstrated a remarkable disease response to zoledronic acid. After 1 year of treatment, there was a complete resolution of lymphadenopathy and disappearance of all somatostatin receptor avid lesions by positron emission tomography-CT and radiopharmaceutical Gallium Ga 68 Dotatate. Stability of disease was further demonstrated by CT over several years.
View Article and Find Full Text PDFMagnetic Resonance-Guided Focused Ultrasound Surgery for Gynecologic Indications.
Magn Reson Imaging Clin N Am
November 2024
Article Synopsis
- MRgFUS is a promising and safe treatment for uterine fibroids and adenomyosis, especially for women looking to preserve their fertility.
- It has shown potential in relieving pain for conditions like endometriosis and recurrent gynecologic cancers, but further research is required.
- Widespread reimbursement for MRgFUS is limited due to insufficient large-scale studies comparing it to standard treatment options.
Article Synopsis
- Patients with ruptured gastrointestinal stromal tumors (GIST) tend to have a worse prognosis and limited information exists on the effect of adjuvant imatinib on their survival.
- A study analyzed the recurrence-free (RFS) and overall survival (OS) of 358 patients with localized GIST, 20% of whom had reported ruptures, finding that those with ruptures experienced lower RFS and OS compared to those without ruptures.
- The study concluded that while adjuvant imatinib for 3 years didn’t significantly enhance survival for ruptured GIST patients compared to 1 year, those with specific genetic mutations showed improved OS with longer treatment.
In this review, a systematic literature search on the effectiveness and complication rates of ultrasound-guided and magnetic resonance-guided high-intensity focused ultrasound (USg-/MRgHIFU) for abdominal wall endometriosis (AWE) was conducted in six databases in May/June 2023. Original articles of (non)randomized trials, cohort studies, case-control studies and case series published in peer-reviewed journals were included. Of the included studies the level of evidence (LoE) and methodological quality using the ROBINS-I and IHE-QAT was assessed.
View Article and Find Full Text PDFObjectives: To assess the environmental impact of the non-invasive Magnetic Resonance image-guided High-Intensity Focused Ultrasound (MR-HIFU) treatment of uterine fibroids, we aimed to perform a full Life Cycle Assessment (LCA). However, as a full LCA was not feasible at this time, we evaluated the CO (carbon dioxide) emission from the MRI scanner, MR-HIFU device, and the medication used, and analyzed solid waste produced during treatment.
Methods: Our functional unit was one uterine fibroid MR-HIFU treatment.